This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of other and unspecified parts of biliary tract
C3_BILIARY_TRACT
biliary tract neoplasm: A neoplasm that involves the biliary tract.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
538 |
4. Check minimum number of eventsNone |
538 |
5. Include endpointsNone |
538 |
6. Filter based on genotype QC (FinnGen only) |
522 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and unspecified parts of biliary tract
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo
- Malignant neoplasm of digestive organs
- Solid cancers, helper endpoint
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 522 | 223 | 299 |
| Unadjusted period prevalence (%) | 0.11 | 0.08 | 0.14 |
| Median age at first event (years) | 71.64 | 71.25 | 71.92 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 538
- Matched controls
- 5380
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A03FA01
ATC
metoclopramide; systemic, rectal
23.7
320.9
325
326
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
127.2
316.5
161
18
Z51.5
ICD-10 Finland
Palliative care
49.0
307.7
240
87
H02AB02
ATC
dexamethasone; systemic
128.9
307.7
212
27
UJK02
NOMESCO Finland
ERCP
62.3
307.7
188
46
130
Kela drug reimbursment
Malignant tumour
+∞
307.7
350
*
K83.1
ICD-10 Finland
Obstruction of bile duct
236.6
307.7
196
13
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
141.4
288.8
145
14
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
95.9
288.1
152
22
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
222.9
198
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
116.3
216.8
111
12
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
54.0
213.8
125
30
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
62.2
213.7
121
25
N02AA05
ATC
oxycodone; systemic
12.8
203.2
303
494
WX302
NOMESCO Finland
Thoracal epidural anesthesy
38.2
190.2
122
41
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
49.1
189.6
113
29
A04AA02
ATC
granisetron; systemic, transdermal
2444.8
182.1
166
*
A04AA01
ATC
ondansetron; systemic, rectal
33.7
178.4
119
45
K83.0
ICD-10 Finland
Cholangitis
57.0
177.7
102
22
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2253.5
172.6
158
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
73.8
168.8
92
15
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
50.3
167.9
99
24
JN4AD
NOMESCO Finland
Body CT examination
16.3
162.9
157
133
L01BC06
ATC
capecitabine; oral
+∞
159.5
145
*
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
296.1
154.0
150
7
JLC30
NOMESCO Finland
Pancreatoduodenectomy
+∞
150.2
137
*
JN4BD
NOMESCO Finland
Extensive body CT
14.9
135.4
134
117
JN4CD
NOMESCO Finland
Very extensive body CT
36.7
131.5
84
27
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
130.7
120
*
C24.0
ICD-10 Finland
Malignant neoplasm: Extrahepatic bile duct
+∞
119.3
110
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
20.2
115.2
93
55
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
110.3
102
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
109.2
101
*
C24.1
ICD-10 Finland
Malignant neoplasm: Ampulla of Vater
+∞
105.8
98
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
40.9
105.6
65
18
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
9.6
101.6
139
189
8160/3-C24.9
ICD-O-3
Cholangiocarcinoma of billiary tract, NOS
+∞
101.3
94
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
95.7
89
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
549.3
95.5
92
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
20.8
94.0
74
41
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
12.6
93.9
100
96
8000/3-C24.9
ICD-O-3
Neoplasm, malignant of billiary tract, NOS
+∞
85.8
80
*
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
921.5
82.8
79
*
JAH01
NOMESCO Finland
Laparoscopy
15.4
82.6
76
57
C24.09
ICD-10 Finland
Biliary duct or passage NOS
+∞
82.5
77
*
WZC00
NOMESCO Finland
Treatment plan or consultation
5.4
82.1
259
792
JN3AD
NOMESCO Finland
Abdominal CT examination
7.3
81.6
144
258
8140/3-C24.1
ICD-O-3
Adenocarcinoma, NOS, of ampulla of Vater
+∞
81.4
76
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.3
80.0
98
114
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.5
77.0
156
320
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
35.0
74.9
48
15
R4190
NOMESCO Finland
Nutritional therapy
19.0
74.9
61
36
C24.02
ICD-10 Finland
Common bile duct
+∞
73.7
69
*
C24.00
ICD-10 Finland
Hepatic duct
+∞
73.7
69
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
6.6
67.8
127
239
WZC30
NOMESCO Finland
Teaching
6.0
67.7
147
319
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
21.2
67.5
52
27
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.0
65.7
141
302
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
13.9
64.3
62
50
R50.9
ICD-10 Finland
Fever, unspecified
5.2
62.0
160
402
8160/3-C24.0
ICD-O-3
Cholangiocarcinoma of extrahepatic bile duct
+∞
60.6
57
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
54.1
51
*
C24.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of biliary tract
+∞
53.0
50
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
51.9
49
*
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
195.5
51.9
53
*
XX3DW
NOMESCO Finland
Time consuming IT work
7.9
51.8
77
112
8140/3-C24.0
ICD-O-3
Adenocarcinoma, NOS, of extrahepatic bile duct
+∞
50.8
48
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
9.0
49.7
65
81
WW500
NOMESCO Finland
Blood transfusion
12.4
48.9
50
44
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
+∞
48.7
46
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.8
45.6
193
687
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
45.5
43
*
B01AB10
ATC
tinzaparin; parenteral
5.7
44.5
92
187
TPX10
NOMESCO Finland
Implantation of vascular injection port
13.3
44.0
43
35
WX402
NOMESCO Finland
General anaesthesia
4.2
43.7
144
429
8000/3-C24.0
ICD-O-3
Neoplasm, malignant of extrahepatic bile duct
+∞
41.2
39
*
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
+∞
40.1
38
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
39.0
37
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
38.0
36
*
R18
ICD-10 Finland
Ascites
14.3
37.7
35
26
WF049
NOMESCO Finland
Radiotherapy of metastasis
393.2
37.5
37
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
36.9
35
*
TPH07
NOMESCO Finland
Cathetrisation of artery
4.3
36.6
111
308
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
56.7
36.0
42
8
J01MA12
ATC
levofloxacin; systemic
3.5
35.6
162
593
A06AH03
ATC
naloxegol; oral
84.0
35.3
39
5
JAH00
NOMESCO Finland
Laparotomy
9.8
35.2
42
46
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
9.5
35.0
43
49
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
34.8
33
*
8140/3-C24.9
ICD-O-3
Adenocarcinoma, NOS, of billiary tract, NOS
+∞
34.8
33
*
B01AB05
ATC
enoxaparin; parenteral
3.1
34.2
223
1007
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
+∞
33.7
32
*
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
+∞
33.7
32
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
33.7
32
*
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
76.8
32.3
36
5
C61
ICD-10 Finland
Malignant neoplasm of prostate
343.0
32.2
32
*
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
175.4
32.1
33
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
31.6
30
*
L03AA02
ATC
filgrastim; parenteral
169.8
31.0
32
*
ZX120
NOMESCO Finland
Intravenous
4.5
27.4
72
177
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.6
27.1
45
73
A04AD12
ATC
aprepitant; systemic
+∞
26.3
25
*
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
+∞
26.3
25
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
25.2
24
*
A02BC02
ATC
pantoprazole; systemic
2.9
25.1
403
2748
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
+∞
24.1
23
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
24.1
23
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
130.8
23.8
25
*
A06AD11
ATC
lactulose; oral
2.8
22.7
140
595
ZXE40
NOMESCO Finland
More than seven and less than nine hours
9.1
21.7
27
31
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
20.8
153
708
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
50.1
20.3
24
5
A05AA02
ATC
ursodeoxycholic acid; oral
18.2
20.3
31
18
C24.01
ICD-10 Finland
Cystic duct
+∞
19.9
19
*
UJK12
NOMESCO Finland
Peroral cholangioscopy
76.5
19.8
22
*
WX004
NOMESCO Finland
Patient-controlled sedation
207.3
19.7
20
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
19.6
111
447
B01AB04
ATC
dalteparin; parenteral
4.8
19.5
46
103
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
19.2
285
1784
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
+∞
18.9
18
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
18.9
18
*
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
40.0
18.7
23
6
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
103.7
18.7
20
*
D77
ICPC
Malignant digestive neopl other/NOS
196.6
18.7
19
*
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
8.1
18.4
25
32
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.7
18.3
118
508
116
Kela drug reimbursment
Prostate cancer
+∞
17.8
17
*
8160/3-C22.1
ICD-O-3
Cholangiocarcinoma of intrahepatic bile duct
+∞
17.8
17
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
17.7
127
575
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
6.3
17.5
30
50
WF002
NOMESCO Finland
Radical radiotherapy
43.5
17.4
21
5
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
51.8
17.1
20
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
16.8
16
*
A79
ICPC
Malignancy NOS
+∞
16.8
16
*
JKA20
NOMESCO Finland
Cholecystectomy
5.4
16.5
33
64
A41.8
ICD-10 Finland
Other specified sepsis
6.6
16.4
27
43
JDE00
NOMESCO Finland
Gastrojejunostomy
+∞
15.7
15
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
39.3
15.5
19
5
D70.82
ICD-10 Finland
Drug-induced neutropenia
46.4
15.1
18
*
K85.8
ICD-10 Finland
Other acute pancreatitis
25.9
14.8
20
8
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
25.9
14.8
20
8
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
14.6
14
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
14.6
14
*
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
82.4
14.6
16
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.7
14.4
34
76
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
14.1
181
1040
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
31.0
14.0
18
6
WVA20
NOMESCO Finland
Medicine administration
5.6
13.7
26
48
WX704
NOMESCO Finland
Intubation
3.4
13.5
51
161
WX002
NOMESCO Finland
Sedation and analgesia
2.2
13.0
126
646
L03AA13
ATC
pegfilgrastim; parenteral
51.3
12.9
15
*
J01MA02
ATC
ciprofloxacin; systemic
2.0
12.8
229
1473
SPAT1255
SPAT
Intravenous administration of medicine
3.3
12.6
50
163
WX892
NOMESCO Finland
Monitored bed care
3.0
12.6
60
218
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
12.5
12
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
12.5
12
*
PJA12
NOMESCO Finland
Sentinel node biopsy
133.0
12.5
13
*
R4110
NOMESCO Finland
Physiotherapy
2.1
12.2
153
864
WX725
NOMESCO Finland
Noninvasive ventilation
3.6
11.8
39
113
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
30.8
11.7
15
5
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
66.4
11.6
13
*
JKC30
NOMESCO Finland
Partial excision of bile duct and anastomosis to jejunum
+∞
11.5
11
*
D76
ICPC
Malignant neoplasm pancreas
+∞
11.5
11
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
17.5
11.3
17
10
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
17.5
11.3
17
10
K75.0
ICD-10 Finland
Abscess of liver
25.6
11.2
15
6
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
44.3
11.0
13
*
K76.9
ICD-10 Finland
Liver disease, unspecified
9.9
10.8
21
22
N02AX02
ATC
tramadol; systemic, rectal
1.9
10.8
238
1613
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
61.2
10.7
12
*
C10AA07
ATC
rosuvastatin; oral
0.4
10.6
56
1237
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
10.4
10
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
10.4
10
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
10.4
10
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
10.4
10
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
10.4
10
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
10.4
10
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
10.4
10
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.7
10.3
23
31
WW200, ,
SPAT
0.3
10.3
27
839
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
13.5
10.2
17
13
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
3.8
10.1
31
85
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
14.9
10.1
16
11
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
40.9
10.0
12
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.1
9.9
27
68
JLB28
NOMESCO Finland
Endoscopic internal drainage of pancreatic duct
56.0
9.7
11
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
8.6
9.6
20
24
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.3
9.6
20
713
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
10.3
9.6
18
18
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
9.4
9
*
115
Kela drug reimbursment
Breast cancer
+∞
9.4
9
*
D02
ICPC
Abdominal pain epigastric
3.2
9.3
37
121
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.4
9.2
33
101
L02AE02
ATC
leuprorelin; implant, parenteral
37.4
9.0
11
*
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
7.0
8.9
21
31
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
3.1
8.9
37
124
A10AB05
ATC
insulin aspart; parenteral
2.6
8.9
54
223
A41.9
ICD-10 Finland
Sepsis, unspecified
3.3
8.6
33
105
ZXD05
NOMESCO Finland
Urgent procedure
1.8
8.5
158
1002
D13
ICPC
Jaundice
91.4
8.4
9
*
WX882
NOMESCO Finland
High dependency care
4.1
8.4
23
58
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
8.4
8
*
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
+∞
8.4
8
*
C25
ICD-10 Finland
Malignant neoplasm of pancreas
+∞
8.4
8
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
8.4
8
*
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
+∞
8.4
8
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
8.2
92
492
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.0
7.8
35
123
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.6
7.8
25
71
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.3
7.8
29
91
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.3
7.6
19
31
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
10.2
7.6
14
14
ZXE20
NOMESCO Finland
More than three and less than five hours
2.1
7.5
73
370
C10AX09
ATC
ezetimibe; oral
0.3
7.4
19
606
A98
ICPC
Health maint/preventive medicine
0.6
7.4
378
4324
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
7.3
47
199
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
7.3
7
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
7.3
7
*
JLA00
NOMESCO Finland
Exploration of pancreas
+∞
7.3
7
*
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
+∞
7.3
7
*
C25.7
ICD-10 Finland
Malignant neoplasm: Other parts of pancreas
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
7.3
7
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
7.3
7
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
7.3
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
+∞
7.3
7
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
7.3
7
*
L02BB03
ATC
bicalutamide; oral
+∞
7.3
7
*
B03XA02
ATC
darbepoetin alfa; parenteral
5.9
7.3
19
33
K81.0
ICD-10 Finland
Acute cholecystitis
4.0
7.2
20
51
ZX090
NOMESCO Finland
Other technic of radiotherapy
30.4
7.2
9
*
WPB10
NOMESCO Finland
Making a convalescent care decision
20.3
7.2
10
5
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.3
7.1
26
81
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.1
6.9
29
98
HAB40
NOMESCO Finland
Wedge excision of mammary gland
17.0
6.8
10
6
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
12.4
6.6
11
9
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
6.6
161
1092
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
5.8
6.5
17
30
R11
ICD-10 Finland
Nausea and vomiting
2.3
6.5
50
231
Y77
ICPC
Malignant neoplasm prostate
70.7
6.4
7
*
JFB30
NOMESCO Finland
Right hemicolectomy
14.5
6.4
10
7
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
18.3
6.3
9
5
JLB12
NOMESCO Finland
Transduodenal endoscopic incision of pancreatic duct orifice
+∞
6.3
6
*
JLD12
NOMESCO Finland
Endoscopic drainage of pancreatic pseudocyst
+∞
6.3
6
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
+∞
6.3
6
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
6.3
6
*
C25.3
ICD-10 Finland
Malignant neoplasm: Pancreatic duct
+∞
6.3
6
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
6.3
6
*
K31.5
ICD-10 Finland
Obstruction of duodenum
+∞
6.3
6
*
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
+∞
6.3
6
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
6.3
6
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
6.3
6
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
JFC00
NOMESCO Finland
Entero-enterostomy
+∞
6.3
6
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
6.3
6
*
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
8.7
6.1
12
14
A10AE04
ATC
insulin glargine; parenteral
2.1
6.0
60
307
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
227
73
53.06
307.65
6.9
1.6
3756.78
12.63
u/ml
0.90
217
56
353
201
49.16
307.65
7.0
1.3
42.80
2.72
ug/l
1.89
327
151
111
36
38.59
174.49
2.2
1.6
69.35
105.71
u/ml
0.13
111
36
216
295
11.56
162.36
5.2
1.8
0.17
0.20
g/l
6.43
206
261
220
389
8.88
131.05
8.6
2.0
49.08
7.34
umol/l
10.67
204
337
125
9
180.31
123.23
1.4
1.1
—
—
—
0
0
99
98
12.15
91.02
1.6
1.3
116.93
316.09
ug/g
12.20
59
59
342
1236
5.85
90.46
8.8
2.2
113.35
59.87
u/l
1.00
334
1136
204
566
5.19
71.26
4.9
2.4
0.77
0.83
mmol/l
7.21
197
516
368
1714
4.63
63.17
14.7
3.3
30.20
35.32
g/l
42.79
360
1559
279
1131
4.05
56.58
9.3
2.5
71.60
33.53
u/l
11.66
267
1072
132
319
5.16
52.94
10.1
2.0
56.41
30.87
u/l
1.47
127
261
387
2054
4.15
50.91
19.3
16.9
1.32
1.36
inr
0.37
115
586
130
353
4.54
44.64
6.4
5.3
7.88
10.89
mmol/l
3.95
125
331
96
242
4.61
35.79
1.6
1.5
—
—
—
0
0
202
851
3.20
35.16
3.7
2.0
—
—
—
0
0
310
1661
3.04
35.14
4.6
2.2
—
—
—
0
0
72
159
5.07
31.36
2.1
1.7
4.57
1.74
ug/l
0.57
67
137
346
2067
2.89
30.42
24.2
5.6
4.61
4.32
e9/l
1.08
317
1800
254
1295
2.82
30.34
8.4
2.0
2.33
2.35
mmol/l
1.86
243
1058
332
2005
2.71
27.48
9.8
5.4
1.19
1.21
mmol/l
4.90
277
1713
160
676
2.95
26.65
2.1
1.8
—
—
—
0
0
309
1822
2.63
26.52
8.6
5.0
1.18
1.21
mmol/l
6.10
297
1609
170
792
2.68
23.06
10.0
2.2
2.51
2.45
mmol/l
7.46
161
673
32
15
22.59
22.39
2.2
1.7
3.25
3.94
nmol/l
0.23
32
15
364
2436
2.53
22.24
10.1
4.1
7.36
6.85
mmol/l
4.29
357
2273
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
53
124
4.63
21.37
2.7
2.7
0.26
0.37
u/ml
1.65
28
74
123
525
2.74
19.48
2.3
2.3
20.01
23.29
%
1.53
114
442
118
499
2.75
18.99
10.2
6.2
0.38
1.45
mmol/l
2.51
98
391
118
501
2.74
18.83
10.2
6.2
4.97
5.15
kpa
1.34
113
480
118
501
2.74
18.83
10.2
6.2
14.39
11.14
kpa
7.95
112
482
76
254
3.32
18.51
1.7
1.4
—
—
—
0
0
346
2368
2.29
18.50
8.8
2.9
290.50
50.14
u/l
22.42
326
2152
123
563
2.54
16.70
2.3
2.2
2.22
2.26
g/l
0.33
117
518
401
2985
2.35
16.61
31.5
5.0
213.11
76.75
u/l
29.89
396
2729
111
492
2.58
16.07
2.1
1.7
—
—
—
0
0
110
489
2.57
15.81
2.0
1.8
—
—
—
0
0
207
1212
2.15
15.65
3.5
3.0
41.76
113.41
e6/l
0.71
166
937
39
94
4.40
15.11
1.6
1.5
—
—
—
0
0
66
231
3.12
14.81
2.3
1.9
11.19
10.82
g/l
0.27
58
213
231
1441
2.06
14.50
3.5
3.0
—
—
—
0
0
268
1768
2.03
14.36
5.3
5.1
20.03
26.74
%
19.03
255
1642
261
1754
1.95
12.79
5.1
5.0
63.36
57.94
%
9.13
249
1630
183
1102
2.00
12.23
3.6
2.9
0.76
0.50
e6/l
0.64
146
837
25
51
5.09
11.79
1.0
1.1
—
—
—
0
0
255
1733
1.90
11.79
5.3
5.0
2.05
2.98
%
11.27
242
1601
17
12
14.58
10.54
1.7
1.1
29.06
28.33
umol/l
0.09
17
12
341
2616
1.83
10.04
5.3
4.4
2.17
3246.23
e6/l
—
6
47
144
851
1.95
9.85
2.8
2.4
7.99
5.13
e6/l
1.32
133
759
21
44
4.93
9.61
1.6
1.2
—
—
—
0
0
22
50
4.54
9.16
2.0
2.0
92.37
90.18
%
1.56
22
50
20
42
4.91
9.13
1.6
1.2
—
—
—
0
0
23
55
4.32
9.00
1.0
1.2
—
—
—
0
0
19
24
8.16
8.92
1.9
1.1
—
—
—
0
0
85
430
2.16
8.83
5.0
3.1
—
—
—
0
0
28
79
3.68
8.79
2.1
2.4
14.72
16.80
%
—
6
38
27
75
3.74
8.67
1.7
1.3
—
—
—
0
0
83
420
2.15
8.60
3.5
3.0
1.10
2.17
mmol/l
1.65
72
352
13
8
16.60
8.59
4.3
1.0
97.00
95.88
%
—
13
8
26
71
3.80
8.55
1.7
1.3
—
—
—
0
0
298
3665
0.58
8.54
4.2
4.5
2.10
2.32
mu/l
0.29
251
3270
344
4072
0.57
8.49
4.3
5.4
2.49
2.63
mmol/l
1.87
294
3679
21
51
4.24
8.06
1.0
1.1
353.81
258.82
u/ml
0.39
16
28
329
3924
0.58
8.04
4.1
4.8
1.33
1.45
mmol/l
4.67
277
3543
109
627
1.93
7.92
3.1
2.8
3.48
2.22
e6/l
0.38
60
339
21
53
4.08
7.68
1.6
1.2
—
—
—
0
0
336
3969
0.59
7.60
4.1
4.8
4.34
4.50
mmol/l
1.76
290
3598
41
161
2.67
7.45
2.2
1.6
—
—
—
0
0
17
39
4.47
7.00
2.9
2.2
—
—
—
0
0
58
1092
0.47
6.85
1.9
1.7
1.39
1.33
mmol/l
0.16
51
904
12
11
11.13
6.82
1.2
1.1
—
—
—
0
0
344
3988
0.62
6.32
4.5
4.9
6.26
6.09
mmol/l
1.05
296
3568
24
77
3.22
6.24
1.1
1.3
—
—
—
0
0
16
39
4.20
6.13
1.3
1.2
—
—
—
0
0
36
149
2.52
5.92
2.1
1.5
—
—
—
0
0
53
267
2.09
5.54
1.9
1.6
—
—
—
0
0
238
2951
0.65
5.51
3.7
3.6
15.03
15.01
pmol/l
0.04
194
2618
326
3785
0.65
5.45
3.8
4.3
1.26
1.28
mmol/l
0.22
279
3379
18
53
3.48
5.35
1.6
1.3
—
—
—
0
0
16
44
3.72
5.24
1.2
1.2
—
—
—
0
0
104
677
1.66
4.85
3.1
2.6
1.63
1.31
e6/l
0.29
56
389
45
225
2.09
4.81
2.1
2.5
1.14
0.23
e6/l
0.83
45
218
335
3835
0.66
4.81
7.5
6.5
41.93
40.80
mmol/mol
1.24
302
3514
147
1048
1.55
4.70
2.4
2.2
3.52
3.05
mg/l
0.61
129
870
15
38
4.03
4.33
1.5
1.1
—
—
—
0
0
125
875
1.56
4.30
4.2
4.0
692.63
381.19
ng/l
0.22
103
734
25
102
2.52
4.28
1.2
1.2
—
—
—
0
0
16
51
3.20
4.24
1.7
1.2
—
—
—
0
0
16
51
3.20
4.24
1.7
1.2
—
—
—
0
0
13
31
4.27
4.03
1.3
1.4
—
—
—
0
0
14
37
3.86
3.92
1.5
1.1
—
—
—
0
0
14
37
3.86
3.92
1.5
1.1
—
—
—
0
0
14
38
3.75
3.82
1.5
1.1
—
—
—
0
0
14
38
3.75
3.82
1.5
1.1
—
—
—
0
0
11
25
4.47
3.64
1.6
1.3
—
—
—
0
0
7
230
0.30
3.54
1.3
1.9
—
—
—
0
0
13
36
3.67
3.51
1.5
1.1
—
—
—
0
0
8
13
6.23
3.51
1.4
1.2
—
—
—
0
0
8
13
6.23
3.51
1.4
1.2
—
—
—
0
0
16
58
2.81
3.45
1.2
1.4
—
—
—
0
0
57
346
1.72
3.44
1.6
1.7
1.47
1.58
%
0.63
49
289
41
225
1.89
3.43
2.2
2.3
0.69
0.64
%
0.36
41
225
14
47
3.03
3.43
1.6
1.2
—
—
—
0
0
17
64
2.71
3.42
2.8
2.8
65.82
61.59
%
0.74
17
64
133
1732
0.69
3.35
4.3
3.9
2.03
2.04
ug/l
0.01
112
1532
218
1775
1.38
3.29
4.2
3.9
25.14
82.01
ng/l
1.39
184
1343
18
72
2.55
3.24
1.4
1.2
—
—
—
0
0
12
34
3.59
3.21
1.6
1.4
—
—
—
0
0
103
1395
0.68
3.17
4.2
3.8
20.29
24.52
%
2.95
58
667
41
232
1.83
3.14
2.2
2.3
1.00
1.15
%
0.84
41
232
8
16
5.06
3.06
1.4
1.2
—
—
—
0
0
12
37
3.29
2.95
1.8
1.3
—
—
—
0
0
12
37
3.29
2.95
1.8
1.3
—
—
—
0
0
16
64
2.55
2.89
2.1
2.4
5.20
5.09
e9/l
0.03
16
64
8
18
4.49
2.80
1.3
1.2
—
—
—
0
0
67
967
0.65
2.80
2.8
2.7
0.61
0.78
ug/l
2.12
50
663
17
74
2.34
2.60
1.8
1.6
—
—
—
0
0
12
44
2.77
2.56
3.3
2.7
655.71
614.62
ml
—
7
32
25
129
1.98
2.54
2.4
3.4
—
—
—
0
0
41
628
0.62
2.24
1.3
1.3
72.91
41.66
iu/ml
0.39
11
200
187
1566
1.30
2.14
2.8
2.6
220.80
134.85
ug/l
2.98
175
1405
5
10
5.04
2.07
1.4
2.1
—
—
—
0
0
412
4376
0.75
2.06
61.9
19.5
4.00
4.48
e12/l
53.25
402
4209
412
4376
0.75
2.06
62.9
19.6
34.79
40.11
%
35.20
376
4007
412
4376
0.75
2.06
62.3
19.7
117.97
135.76
g/l
84.21
405
4274
412
4374
0.75
2.03
61.9
19.5
257.74
241.56
e9/l
4.14
402
4226
13
270
0.47
2.02
2.1
2.6
—
20.09
—
0
7
180
1511
1.29
2.00
4.1
3.9
—
—
—
0
0
7
21
3.36
1.97
2.9
2.6
—
—
—
0
0
174
1459
1.28
1.95
3.7
3.0
1404.98
1739.77
ng/l
0.51
154
1236
9
34
2.67
1.87
1.0
1.4
—
—
—
0
0
223
1943
1.25
1.79
4.0
3.7
0.00
0.00
estimate
0.50
62
351
13
60
2.20
1.79
2.3
1.5
—
—
—
0
0
19
102
1.89
1.78
1.6
1.3
—
—
—
0
0
19
102
1.89
1.78
1.6
1.3
—
—
—
0
0
5
13
3.87
1.72
1.0
1.0
—
—
—
0
0
5
13
3.87
1.72
1.0
1.0
—
—
—
0
0
12
238
0.49
1.67
1.1
1.4
—
51.99
—
0
15
8
31
2.60
1.66
1.4
1.1
—
—
—
0
0
8
31
2.60
1.66
1.4
1.1
—
—
—
0
0
8
31
2.60
1.66
1.4
1.1
—
—
—
0
0
224
1966
1.24
1.65
4.0
3.7
0.00
0.00
estimate
-0.00
55
318
221
1939
1.24
1.63
5.2
5.0
0.00
0.00
estimate
-0.00
57
318
38
255
1.53
1.63
3.5
3.5
2.12
2.10
mmol/l
0.01
27
195
6
20
3.02
1.58
1.0
1.2
—
—
—
0
0
11
50
2.23
1.58
1.0
1.4
—
—
—
0
0
8
33
2.45
1.54
1.4
1.3
—
—
—
0
0
185
1604
1.23
1.50
2.4
2.2
68.85
79.03
nmol/l
5.37
174
1387
112
1349
0.79
1.48
1.9
2.1
164.99
271.06
u/l
0.96
103
1255
44
606
0.70
1.46
1.3
1.3
1.38
13.36
u/ml
3.99
15
230
5
16
3.14
1.44
1.0
1.0
—
—
—
0
0
6
22
2.75
1.44
1.0
1.4
—
—
—
0
0
127
1063
1.25
1.41
4.4
3.9
0.00
0.00
estimate
-0.00
47
313
24
150
1.63
1.40
1.4
2.2
44.63
41.12
u/l
0.39
19
126
352
3744
0.83
1.29
42.8
12.4
80.03
74.29
ml/min/173m2
5.76
312
3027
8
36
2.24
1.24
1.4
1.3
—
—
—
0
0
96
808
1.23
1.03
2.9
1.6
3.59
1.24
mg/l
2.02
85
628
5
108
0.46
1.02
1.2
1.2
—
2.89
—
0
15
126
1444
0.83
1.02
3.0
3.1
7.63
7.48
mmol/l
0.14
91
1189
10
169
0.58
0.89
1.7
1.7
—
—
—
0
0
407
4226
0.85
0.87
34.3
8.9
43.04
25.28
u/l
18.53
402
4015
6
30
2.01
0.87
1.0
1.0
—
—
—
0
0
6
31
1.95
0.84
1.2
1.3
118.00
44.64
u/l
—
6
26
12
74
1.64
0.78
1.0
1.3
—
—
—
0
0
6
110
0.54
0.72
1.2
1.2
—
4.78
—
0
18
407
3923
1.15
0.72
46.8
13.4
43.39
24.43
mg/l
19.31
399
3083
7
40
1.76
0.71
1.0
1.1
—
—
—
0
0
410
4230
0.87
0.67
49.2
16.6
3.94
4.00
mmol/l
5.21
404
4094
11
70
1.58
0.65
3.9
2.3
105.91
105.07
mmol/l
0.24
11
70
11
70
1.58
0.65
3.9
2.3
4.10
4.13
mmol/l
0.07
11
70
136
1495
0.88
0.63
3.7
3.7
8.28
7.59
mg/mmol
0.10
83
930
6
104
0.57
0.62
1.2
1.2
602.00
472.03
mg/l
—
6
96
14
96
1.47
0.62
1.6
1.9
118.22
136.01
g/l
—
9
69
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
64
742
0.84
0.61
1.3
1.2
4.60
1.61
u/ml
0.34
12
210
46
550
0.82
0.60
4.2
5.1
32.57
32.27
%
0.05
28
347
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
410
4220
0.88
0.60
49.2
16.6
137.44
139.76
mmol/l
37.09
404
4087
0
23
0.00
0.58
0.0
1.1
—
1.10
—
0
13
10
149
0.66
0.57
1.5
1.6
—
—
—
0
0
5
90
0.55
0.56
1.0
1.2
—
2.69
—
0
7
13
182
0.71
0.55
1.0
1.2
540.60
104.51
iu/ml
—
5
70
49
569
0.85
0.49
14.5
7.3
—
—
—
0
0
18
138
1.31
0.46
3.3
2.4
82.40
102.60
ug/min
—
10
88
5
85
0.58
0.45
1.8
1.1
—
49.55
—
0
6
6
91
0.66
0.42
1.0
1.2
—
—
—
0
0
11
150
0.73
0.42
1.0
1.0
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
7.6
—
38.17
—
0
6
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
9
68
1.33
0.37
1.1
1.4
—
—
—
0
0
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
9
121
0.74
0.35
1.3
1.4
—
—
—
0
0
183
1920
0.93
0.33
2.8
2.3
—
—
—
0
0
102
1096
0.91
0.33
2.6
2.4
7198.38
10116.82
umol/l
0.17
85
932
6
90
0.66
0.33
1.2
1.2
4.88
3.94
mmol/l
—
6
83
324
3329
0.93
0.32
54.8
15.5
15.50
15.30
%
0.41
324
3251
36
321
1.13
0.25
3.9
2.2
68.69
58.97
ml/min/173m2
0.95
13
127
9
75
1.20
0.25
1.0
1.1
—
—
—
0
0
12
96
1.26
0.24
1.4
1.4
—
—
—
0
0
10
126
0.79
0.24
1.2
1.6
—
—
—
0
0
105
1108
0.93
0.23
1.7
1.5
19.46
20.56
nmol/l
0.38
97
936
5
41
1.22
0.22
2.4
2.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
9.34
—
0
11
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
9
115
0.78
0.20
1.1
1.2
—
—
—
0
0
9
115
0.78
0.20
1.1
1.2
—
—
—
0
0
6
51
1.18
0.19
4.5
3.5
—
—
—
0
0
7
59
1.19
0.18
1.3
1.1
—
—
—
0
0
303
2974
1.04
0.17
4.4
4.1
23.99
12.96
mm/h
12.33
275
2680
6
78
0.77
0.15
1.5
1.4
—
—
—
0
0
94
909
1.04
0.11
4.3
4.1
1.02
1.02
kg/l
0.34
21
150
98
1011
0.96
0.10
1.7
1.7
200000530.51
16093804.41
pmol/l
0.44
81
814
93
952
0.97
0.07
1.9
1.7
1271.97
1205.24
nmol/l
0.27
78
710
11
101
1.09
0.04
2.1
1.6
—
—
—
0
0
41
422
0.97
0.04
1.3
1.3
—
—
—
0
0
35
359
0.97
0.02
1.4
1.4
—
—
—
0
0
188
1872
1.01
0.01
2.0
2.1
87.59
93.05
pmol/l
0.82
105
961
11
105
1.05
0.00
1.5
1.6
11129.20
15454.09
e6/l
—
5
76
17
166
1.02
0.00
1.2
1.3
—
—
—
0
0
15
148
1.01
0.00
1.3
1.3
—
—
—
0
0
10
99
1.01
0.00
2.3
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
2.3
—
1.25
—
0
9
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
76.29
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
-0.00
1.2
1.3
0.50
0.62
nmol/l
—
5
52
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
55
0.91
-0.00
1.4
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_BILIARY_TRACT – Malignant neoplasm of other and unspecified parts of biliary tract
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).